Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer's Disease
-
Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society
-
Matthews International Completes Senior Notes Offering
-
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma
-
ShipperGuide TMS Named a Leader in the G2 Grid® for Transportation Management Systems
-
Adaptive Research Announces it has Begun Enrolling Patients in AriBio’s Phase 3 POLARIS-AD Clinical Trial
-
Superluminal Medicines Announces Formation of Scientific Advisory Board
-
Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities
-
The Future is Now: Confronting Today’s Healthcare Challenges and Shaping Tomorrow’s Care at Empower
-
Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study
-
Epilepsy Foundation Awards $200,000 at 12th Annual Shark Tank Competition
-
Merus Announces First Patient Dosed in LiGeR-HN1, a Phase 3 Trial Evaluating Petosemtamab in Combination with Pembrolizumab in 1L r/m HNSCC
-
Nano Hearing Aids® Launches New Innovative "Completely in Canal" Hearing Aids
-
Redwood Logistics and LK® Packaging Dish Out Supply Chain Efficiency, Achieving Six-Figure Savings
-
Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024
-
IGI Announces CRADA with National Cancer Institute to Test Proprietary Oral Cbl/b Inhibitor Treatment in Triple Negative Breast Cancer
-
Aligos Therapeutics to Present at Investor Conferences in October
-
Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting
-
ManTech Releases Premier Open-Source Reference Architecture for Digital Engineering Environment
-
Shoals Technologies Group Appoints Chief Operations Officer and Interim Chief Legal Officer
-
Casella Waste Systems, Inc. Announces Closing of $1.5 Billon Amended and Restated Credit Facility
-
Wellinks Acquires Spire Health Creating Industry Leader in Predictive Patient Care for Cardiopulmonary Health
-
CareCloud and ChartSwap Partner to Launch "CareCloud Powered by ChartSwap" to Streamline the Request for Information Process
-
BDev Ventures Announces Strategic Investment in Personal AI
-
The Oncology Institute of Hope & Innovation Launches Oregon Market
-
Notice to General Meeting
-
Osisko Announces Agreement to Purchase Royalties on Spartan Resources’ Dalgaranga Gold Project in Western Australia
-
Sascha Pallenberg and Rikesh Shah headline the Tomorrow.Mobility congress
-
Play to earn in Etaku - where Ecchi art meets Web3 gaming
-
HPH to Hold Extraordinary General Meeting and Class Meeting On October 31, 2024
-
Management Dealing in Securities
-
Volcon CEO John Kim Shares Important Company Update
-
Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners
-
Opthea to Participate in the UBS Virtual Ophthalmology Day 2024
-
Angitia Biopharmaceuticals Presents First-in-Human Data on AGA2118 for Osteoporosis at ASBMR 2024
-
Altimmune Completes Enrollment in Phase 2b IMPACT Trial of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
-
Gaming and Leisure Properties Promotes Brandon Moore to Additional Role of President
-
ZenaTech Announces Approval to List Common Shares on the Nasdaq Capital Market
-
MariMed’s Betty’s Eddies Partners With Keep A Breast Foundation to Promote Breast Cancer Screening Education
-
Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on October 7, 2024
-
DeFi Technologies Subsidiary Valour launches Asset-backed Ethereum Physical Staking ETP for Professional Investors on the London Stock Exchange
-
Traws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro Inhibitor
-
ZenaTech Announces Approval to List Common Shares on the Nasdaq Capital Market
-
BridgeBio Completes Enrollment of FORTIFY, Phase 3 Registrational Study of BBP-418 in Limb-girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9)
-
BrightSpring Health Services, Inc. Welcomes Dr. Steve Miller to Board of Directors
-
Invesco Ltd: Form 8.3 - Anglogold Ashanti PLC; Public dealing disclosure
-
Adeia to Present at Upcoming Conferences on Hybrid Bonding Technology
-
Parsons to Announce Third Quarter 2024 Financial Results on October 30, 2024
